Infliximab (anti-TNF-alpha)

Catalogue Number: A2019-SEL

Manufacturer:	Selleck Chemicals
Type:	Recombinant Monoclonal
Shipping Condition:	Dry Ice
Unit(s):	5 mg, 1 mg, 25 x 1 mg

Overview
Datasheets

Additional Text

CAS Number

170277-31-3

Short Description

Infliximab (anti-TNF-alpha) is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody that consists of mouse heavy and light chain variable regions combined with human heavy and light chain constant regions. Infliximab neutralizes the biological activity of TNF-α by binding with high affinity to the soluble and transmembrane forms of TNF-α, and inhibits or prevents the effective binding of TNF-α with its receptors. MW=144.2 kDa.

Storage Note

Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

A2019 MSDS

Inhibitor Handling Instructions

A2019 Datasheet

Price

£800.00

-

Quantity
Unit Size

Find out about delivery